Lack of interaction between atazanavir and lansoprazole.
Kosel
Bradley W
BW
Storey
Sheryl S
SS
Collier
Ann C
AC
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000328:Adult; D000897:Anti-Ulcer Agents; D000069446:Atazanavir Sulfate; D000075202:Contraindications; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D064747:Lansoprazole; D008297:Male; D009842:Oligopeptides / Q000627:therapeutic use*; D009853:Omeprazole / Q000031:analogs & derivatives*; D054328:Proton Pump Inhibitors; D011725:Pyridines / Q000627:therapeutic use*
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D009842:Oligopeptides; D054328:Proton Pump Inhibitors; D011725:Pyridines; D064747:Lansoprazole; D000069446:Atazanavir Sulfate; D009853:Omeprazole